Invest in the future of medicine

Would you like to invest in MediCrops Holding AG? Do you have any questions about investment opportunities? 
 Invest now!

Investors

Continuity, transparency and trust — that is what Investor Relations stands for at MediCrops Holding AG. MediCrops® is an internationally operating pharmaceutical company headquartered in Switzerland specializing in prescription-only cannabis preparations containing THC. Our subsidiary MediCrops® North Macedonia possesses an official licence issued by the Ministry of Health. In conformity with the highest GMP (good manufacturing practice) standards, it will operate a high-tech indoor cultivation for the production and development of pharmaceuticals in their in-house laboratory. Thanks to our excellent market position, our long-standing experience and our international network composed of internal and external highly qualified specialists, there are outstanding growth opportunities on the international markets. We would be delighted if we succeeded in arousing your interest in our company. Trust our expertise and rely on our future-proof business model.

«Medicinal cannabis is a new future billion-dollar market.»

– Peter Thiel, Investor (u.a. Facebook, Paypal)

Sustainable cultivation

Medicinal THC offers a wide range of health benefits. Sustainability takes centre stage with us.

Professional processing

Our preparations are produced in accordance with the most stringent quality guidelines.

Fast and secure distribution

The prompt supply of our partners in the healthcare sector is always guaranteed.

We are looking forward to your message